<i>MT‐RNR1</i> genotype testing for preventing aminoglycoside‐mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

John H. McDermott, Sian Hilton, Cinzia Dello Russo, Nicola Booth, Simon Drysdale, Philip Howard, Stephen Hughes, Mallinath Chakraborty, Helen McDevitt, Charlotte Alston, Maya Desai, Mike Beadsworth, Adam Reynolds, Serim Min, Katherine Payne, Munir Pirmohamed, William G. Newman

Open source

DOI: 10.1002/bcp.70712
Published: 2026-07-29
Container: British Journal of Clinical Pharmacology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/bcp.70712,
  title = {<i>MT‐RNR1</i>
                    genotype testing for preventing aminoglycoside‐mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)},
  author = {John H. McDermott and Sian Hilton and Cinzia Dello Russo and Nicola Booth and Simon Drysdale and Philip Howard and Stephen Hughes and Mallinath Chakraborty and Helen McDevitt and Charlotte Alston and Maya Desai and Mike Beadsworth and Adam Reynolds and Serim Min and Katherine Payne and Munir Pirmohamed and William G. Newman},
  year = {2026},
  journal = {British Journal of Clinical Pharmacology},
  doi = {10.1002/bcp.70712},
  url = {https://doi.org/10.1002/bcp.70712}
}

RIS

TY  - JOUR
TI  - <i>MT‐RNR1</i>
                    genotype testing for preventing aminoglycoside‐mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)
AU  - John H. McDermott
AU  - Sian Hilton
AU  - Cinzia Dello Russo
AU  - Nicola Booth
AU  - Simon Drysdale
AU  - Philip Howard
AU  - Stephen Hughes
AU  - Mallinath Chakraborty
AU  - Helen McDevitt
AU  - Charlotte Alston
AU  - Maya Desai
AU  - Mike Beadsworth
AU  - Adam Reynolds
AU  - Serim Min
AU  - Katherine Payne
AU  - Munir Pirmohamed
AU  - William G. Newman
PY  - 2026
JO  - British Journal of Clinical Pharmacology
DO  - 10.1002/bcp.70712
UR  - https://doi.org/10.1002/bcp.70712
ER  -

APA

McDermott, J. H., Hilton, S., Russo, C. D., Booth, N., Drysdale, S., Howard, P., Hughes, S., Chakraborty, M., McDevitt, H., Alston, C., Desai, M., Beadsworth, M., Reynolds, A., Min, S., Payne, K., Pirmohamed, M., & Newman, W. G. (2026). <i>MT‐RNR1</i> genotype testing for preventing aminoglycoside‐mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx). British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70712

Source records

crossref · retrieved 2026-09-26T13:42:35.833Z